| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Controller
1 company
Cai Veronica serves as a Controller at GYRE. Across recent SEC filings that breaks down to 1 buy and 0 sells. Those positions are worth an estimated $49K at current prices.
The biggest single holding is GYRE (~$49K) as Controller. Net of sales, the recent Form 4 record there shows accumulation of 2,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 13, 2020 | GYRE Gyre Therapeutics, Inc. | Controller | Buy | 2,000 | $4.11 | $8,220.00 | +37.4% |